Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center.
D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced*; D002764:Cholecystitis / Q000139:chemically induced; D002769:Cholelithiasis / Q000139:chemically induced; D004341:Drug Evaluation; D004967:Estrogens / Q000009:adverse effects* / Q000627:therapeutic use; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005705:Gallbladder Diseases / Q000139:chemically induced* / Q000601:surgery; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D010689:Phlebitis / Q000139:chemically induced; D011655:Pulmonary Embolism / Q000139:chemically induced; D013923:Thromboembolism / Q000139:chemically induced*; D013924:Thrombophlebitis / Q000139:chemically induced; D013997:Time Factors
D004967:Estrogens; D004966:Estrogens, Conjugated (USP)